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Two-pore channels (TPC1–3) are recently identiﬁed endolysosomal ion channels. The mechanism by
which these channels are regulated at the molecular level is presently unclear. To identify putative
protein regulators of TPCs, we performed unbiased transcriptome-wide screens using the yeast two-
hybrid technique to identify potential protein–protein interactions with the intracellular domains
of human TPC2. We now present biochemical evidence for a novel molecular interaction between
human TPC1/2 and the anti-apoptotic protein Hax-1 (HCLS-associated X-1). The observed binding
of Hax-1 to TPCs may represent a conserved mechanism by which these endolysosomal ion channels
are regulated.
Structured summary of protein interactions:
Hax-1 binds to TPC1 by pull down (View interaction)
TPC2 physically interacts with Hax-1 by two hybrid (1, 2)
TPC2 physically interacts with Hax-1 by anti tag coimmunoprecipitation (View interaction)
TPC2 binds to Hax-1 by pull down (View interaction)
TPC1 physically interacts with Hax-1 by two hybrid (View interaction)
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The two-pore channels (TPC1, 2 and 3) constitute a novel family
of endolysosomal ion channels. TPCs belong to the six transmem-
brane (6TM) ion channel superfamily and show homology with
voltage-gated ion channels. These channels are known to have an
‘intermediate’ channel structure, consisting of two 6TM domains
with each containing a pore-forming loop. Thus, TPCs are thought
to be an evolutionary intermediate between single 6TM and four
6TM channels. TPCs are encoded by three non-allelic genes and
are present in echinoderms and most vertebrates [1]. Notably,
the TPC3 is selectively absent in some rodent and primate species
including Homo sapiens [1]. Transcripts of TPCs can be found in
most human and mouse tissues, suggesting an ubiquitous function
[2,3].TPCs are exclusively expressed in the endolysosomal system.
TPC1 has a wider distribution within the endolysosomal system
and can be found in the early endosomes and recycling endosomes
[2,4]. TPC2, in contrast, is mostly lysosomal [2,5]. The lysosomal
localization of TPC2 is determined by an acidic di-leucine motif
located in its N-terminus ([6] and our unpublished observations).
Both TPC1 and TPC2 are N-glycosylated consistent with their
post-golgi localization [2,7], which may afford protection in the
harsh acidic environment of endolysosomes.
The role of TPCs remains unclear due to conﬂicting reports. TPCs
were ﬁrst cloned in 2000 [8] and were later reported to be an
important determinant of NAADP-induced Ca2+ release [2,3,5]. This
has been supported by a large body of expression manipulation
evidence [2,3,5,9] including overexpression, knockdown and
knockout models, which is consistent with the endolysosomal
localization of these channels. Recent evidence however, examin-
ing directly the macroscopic ion channel activity of TPCs, suggested
that TPCs may be Na+-selective channels regulated by PI(3,5)P2 and
ATP, while they appeared to be insensitive to NAADP [10,11]. A fur-
ther complicating issue is that the reported biophysical properties
of TPCs seem to vary across studies [6,10,12,13], with particular
discrepancies existing between the macroscopic properties of
recombinant human TPC2 (hTPC2) and single-channel properties
of the putative NAADP-activated current [10,12].
3783 A.K.M. Lam et al. / FEBS Letters 587 (2013) 3782–3786Whether TPCs may be regulated by auxiliary subunits is un-
known. Ion channel function is able to be exquisitely regulated
by its associating subunits. These subunits are often known as beta
subunits of their parent channel and are involved in regulating
channel function by, for example, modifying inactivation kinetics
[14], gating properties [15] and surface expression [16]. For intra-
cellular channels such as the IP3 receptor channel, the ryanodine
receptor channel and the ClC-7 Cl/H+ exchanger, auxiliary sub-
units can act as scaffolds for protein kinases/phosphatases [17],
or are required for gating modulation [18,19], agonist sensitivity
[20] or for protein stability [21].
Previously, three studies have provided evidence that TPC2
associates with TRPML1 [22], the Leucine-rich repeat kinase 2
(LRRK2) [23] and the mammalian target of rapamycin (mTOR)
[11]. To identify additional protein interactors of hTPC2 in an unbi-
ased manner, we performed yeast two-hybrid (Y2H) screens using
the intracellular domains of hTPC2 as the ‘bait’ to identify potential
protein regulators of hTPC2 from a human heart cDNA library. We
now provide biochemical evidence for a novel interaction between
human TPC1/2 and Hax-1 (HCLS-associated X-1).2. Materials and methods
2.1. Molecular cloning of TPC plasmid constructs
The human TPC1 and TPC2 IMAGE clones were obtained from
SourceBioscience (IMAGE clones 40148827 and 5214862, respec-
tively). hTPC2 cytosolic domains (hTPC2(1–85), (313–435) and
(694–752)) were PCR-ampliﬁed and were cloned into both the
Y2H pGBKT7 and pACT2 vectors (Clontech) using the following
primers, hTPC2(1–85) Forward: 50-TGCTCCATGGCGGAACCCCAGG
CGGA-30
Reverse: 50-AATTGTCGACTAAGTCCGTTGGCATACGTTCG-30hTPC
2(313–435) Forward: 50-TTACGAATTCAGTCAGTTCCGGGGCTACC-30
Reverse: 50-TTCGGTCGACTAGTCAAAGTAGTAGTGGCCGAA-30hT
PC2(694–752) Forward:50-TAGGCCATGGAGAACTTCCTTCACAAGT-30
Reverse: 50-ATGTGTCGACGTCACCTGCACAGCCACA-30
Human TPC1 C-terminal domain (hTPC1(686–816)) was PCR-
ampliﬁed and cloned in pGBKT7 using the following primers,
Forward: 50-AAGCGGATCCTCGAGGCCTTCGTCTTC-30
Reverse: 50-AATTGTCGACTAGGTAACGGTCTGGGAGCGCT-30.
GST fusion constructs for bacterial expression were made by
sub-cloning into pGEX vector (GE Healthcare). For mammalian
expression, constructs were sub-cloned into modiﬁed pCR3 vector
(Invitrogen) containing cMyc or HA epitope tags at the N-terminus.2.2. Y2H cDNA library screen
First, pACT2 plasmids containing the human heart cDNA library
(AD plasmids, Clontech) were ampliﬁed in and puriﬁed from the
Escherichia coli strain DH5a on standard solid support (LB-agar)
to ensure the growth of the less abundant clones. Y2H was per-
formed as previously described [24]. Brieﬂy, CG1945 (a strain of
Saccharomyces cerevisiae) pre-transformed with individual hTPC2
BT constructs was transformed with 400 lg human heart cDNA
library plasmid using the lithium acetate method. Co-transfor-
mants were then plated on solid SD medium lacking histidine for
histidine growth selection for up to 14 days. Only cells transformed
with plasmids encoding for an interacting pair of proteins can sur-
vive, as this enables transcription of the HIS3 gene allowing de
novo histidine synthesis. 5 mM 3-aminotriazole (3-AT), a competi-
tive inhibitor of histidine synthase, was also included in the med-
ium to suppress background growth, as constitutive expression of
the HIS3 gene can occur at low levels even in untransformed
CG1945. Any CG1945 colonies that appeared on medium lackinghistidine were then reassessed for histidine growth and the
expression of beta-galactosidase. AD plasmids of CG1945 that were
dual positive in both assays were then isolated and were ampliﬁed
in the E. coli strain DH5a, puriﬁed and sequenced. Isolated AD plas-
mids were re-transformed into the yeast strain Y190 for further
veriﬁcation using liquid beta-galactosidase assays (o-nitrophenyl
b-D-galactopyranoside as substrate).
2.3. Puriﬁcation of GST fusion proteins from E. coli
E. coli Rosetta transformed with the GST fusion construct of
interest was grown in 400 ml LB-ampicillin at 37 C. IPTG was
added at a ﬁnal concentration of 100 lM to the culture when the
OD600 was 0.5 to induce protein expression for an additional 3 h
at 25 C. Cells were harvested and resuspended in PBS buffer
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4,
pH 7.4 supplemented with Complete protease inhibitors (Roche))
and was homogenized by three freeze–thaw-sonication cycles. Cell
debris and insoluble material were removed by centrifugation at
10000g for 10 min at 4 C. To capture the GST-tagged proteins,
the soluble fraction was then incubated overnight with 1 ml of glu-
tathione-Sepharose beads (GE healthcare) at 4 C. The beads were
then subjected to two 10 min washes in PBS/0.5% Triton X-100 fol-
lowed by a ﬁnal 10 min wash in PBS. The captured GST-tagged pro-
teins were eluted in elution buffer (10 mM reduced glutathione,
50 mM Tris, pH 8.0) at room temperature for 15 min, concentrated
and buffer-exchanged for PBS using the Vivaspin 20 concentrator
(10 kDa cut-off, VivaScience). The concentrated, puriﬁed proteins
were stored at 80 C until required.
2.4. Mammalian cell and in vitro protein expression
HEK293 cells were propagated in antibiotic-free DMEM (Invit-
rogen) supplemented with 10% fetal bovine serum in a humidiﬁed
atmosphere of 5% CO2 at 37 C. Expression plasmid constructs re-
quired for co-IP experiments were co-transfected into HEK293
cells using the standard calcium phosphate precipitation method.
Cells were harvested 24 h post-transfection.
In vitro protein expression (driven from the T7 promoter in
pGBKT7 constructs) resulting in [35S]radiolabelled proteins was
performed using the TnT system (Promega) as previously described
[24]. hTPC2(694–752) did not express in the TnT system.
2.5. GST pull-down assay
In vitro expressed, [35S]labelled hHax-1(178–279) was solubi-
lized in IP buffer (20 mM Tris, 150 mM NaCl, 0.4% CHAPS, pH 7.4)
and the soluble fraction was incubated overnight at 4 C with 1 lM
GST-hTPC2(694–752) or GST alone captured on glutathione-beads
followed by twowashes with IP buffer. In reciprocal GST pull-down
assays, in vitro-expressed [35S]labelled hTPC1(686–816) were solu-
bilized and incubated with 5 lM GST-hHax-1(178–279) or GST
alone under conditions identical to the above. Captured radiola-
belled proteins were eluted with SDS–PAGE loading buffer (60 mM
Tris, 2% SDS, 10% glycerol, 5 mM EDTA, 2% beta-mercaptoethanol,
0.01% bromophenol blue, pH 6.8), separated by SDS–PAGE andwere
visualized by autoradiography.
2.6. Co-immunoprecipitation (co-IP)
HEK293 cells transiently co-expressing HA-hTPC2 and cMyc–
hHax-1 were homogenized on ice in buffer (20 mM Tris, 150 mM
NaCl, pH 7.4 supplemented with Complete protease inhibitors
(Roche)) by passing 20 times through a 23G needle coupled with
glass beads (Sigma). Nuclei were removed by centrifugation at
1500g for 5 min at 4 C, and the supernatant was solubilized
Fig. 1. Y2H analysis of library positive clones. (A) Expression of Gal4-DNA binding domain fusion constructs (bait) in CG1945: 100 lg of yeast protein extract was resolved
through 12% SDS–PAGE gel and analysed by Western blotting using anti-cMyc. The expected sizes for pGBKT7, hTPC2-NT, hTPC2-MD and hTPC2-CT are 21, 30, 34 and 27 kDa,
respectively. (B) A total of 251 individual colonies selected from the Y2H screen using TPC2(694–752) as the bait were assayed for growth on medium lacking histidine (left)
and for beta-galactosidase activity (right). The intensities of both should give a relatively reliable measure of the relative strength of the potential interaction. The heat maps
show the distribution of the performance of all colonies; each box represents the performance of the original colony in both assays. (C) Quantitative liquid beta-galactosidase
assays of yeast Y190 co-transformed with the indicated bait plasmids and Hax-1(178–279)AD: mean values of beta-galactosidase units obtained from ﬁve individual colonies
per sample. Results are normalized against the positive control pair pVA3 + pTD1 (pVA3 encodes for GAL4 DNA-BD fusion with p53 protein; pTD1 encodes for GAL4 AD fusion
with SV40 large T antigen).
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centrifugation at 20000g for 10 min at 4 C and the cell lysate
was saved. one microgram anti-HA (Y-11, rabbit polyclonal, Santa
Cruz Biotechnology) or non-immune rabbit IgG (Santa Cruz
Biotechnology) was captured overnight onto 20 ll of protein A-Se-
pharose beads (GE healthcare) at 4 C. The anti-HA-coupled protein
A-Sepharose beads were then incubated with 200 ll HEK293 cell
lysate for 6 h at 4 C. Beads were recovered at 1500g for 2 min
and subjected to two 10 min washes with IP buffer. Immunopre-
cipitated proteins were eluted with SDS–PAGE loading buffer, sep-
arated by SDS–PAGE and visualized by Western blot.
2.7. Western blotting
Protein samples were boiled at 95 C for 5 min and the insoluble
material was removed by centrifugation at 14000g for 3 min
prior to gel loading. Proteins resolved through SDS–PAGE gel were
transferred onto a PVDF membrane (Immobilon P, Millipore
(Merck)) using a semi-dry transfer system (Trans-Blot SD, Bio-
Rad) in buffer (48 mM Tris, 39 mM glycine, 0.0375% SDS, 20%
methanol) at 400 mA for 1 h. The membrane was blocked with
5% non-fat milk protein (Marvel) in TBS-T buffer (20 mM Tris,
137 mM NaCl, 0.1% Tween-20, pH 7.4) for 2 h at room temperatureand was subsequently incubated overnight at 4 C in anti-cMyc
(9E10, mouse monoclonal, Santa Cruz Biotechnology, 1:500 dilu-
tion) or anti-HA (16B12, mouse monoclonal, Covance, 1:1000
dilution). The membrane was then incubated in goat anti-mouse
IgG-HRP (Santa Cruz Biotechnology, 1:10000 dilution) at room
temperature for 2 h before visualizing using the enhanced chemi-
luminescence kit (Pierce).
3. Results
3.1. Identiﬁcation of hHax-1 as a novel hTPC2-binding protein
To identify novel hTPC2-binding proteins, we performed tran-
scriptome-wide screens using the Y2H technique. Y2H screening
was separately performed with either the N-terminus (NT, 1–85),
the middle domain (MD, 313–435) or the C-terminus (CT, 694–
752) of hTPC2, which were fused to the Gal4 DNA binding domain,
known as the ‘bait’. Having conﬁrmed the expression of these
fusion proteins (Fig. 1A), a human heart cDNA library, fused to
the Gal4 activation domain (AD), was co-expressed with the NT-
bait, the MD-bait or the CT-bait in CG1945 cells. Positive colonies
surviving in medium lacking histidine were collected, which were
further tested for the expression of the second reporter protein, i.e.
Fig. 3. Co-immuniprecipitation of TPC2 and Hax-1 in HEK293 cells. HA-TPC2 was
immunoprecipitated with anti-HA from solubilized HEK293 cells transiently
expressing HA-TPC2 and cMyc–Hax-1, or HA-TPC2 alone. Immunoprecipitated
proteins were resolved through separate 12% SDS–PAGE gels loaded with 9/10th (A)
or 1/10th of IP samples (B) and analyzed by Western blotting using anti-cMyc (A) or
anti-HA (B). An aliquot of HEK293 cell lysate corresponding to 1% of the amount
processed in the co-IP assay was included in the gels as indicated. The bands at
50 kDa in panel A are the IgG heavy chain of the immunoprecipitating antibodies.
The arrow indicates the expression and co-immunoprecipitation of cMyc–Hax-1
(expected size of 32 kDa). HA-TPC2 has a predicted molecular weight of 84 kDa
(monomeric, non-glycosylated form); the observed immunoreactivity at 140 kDa
corresponds to the fully-glycosylated monomeric form, whereas the higher MW
band is likely to correspond to the dimeric form of TPC2.
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resulted in a considerable number of dual-positive clones (Fig. 1B),
while Y2H screens performed with the NT-bait and MD-bait did
not yield any dual-positive colonies. One of the clones, which ap-
peared 7 times in the screen as full or partial cDNA sequence,
was identiﬁed by nucleotide sequence analysis as hHax-1 (human
HCLS-associated X-1). This was further tested by retransforming
yeast Y190 with the hTPC2 intracellular domain constructs and
the isolated, minimal interacting domain of hHax-1 (residues
178–279). Quantitative, liquid beta-galactosidase assays indicated
that the hHax-1 interaction is speciﬁc for the C-terminus but con-
served across the two human TPC isoforms (Fig. 1C).
3.2. hTPC2 directly binds hHax-1
To conﬁrm that the C-terminus of hTPC2 indeed directly inter-
acts with hHax-1, we performed GST pull-down assays using puri-
ﬁed GST-tagged hTPC2-CT. As shown in Fig. 2A, GST pull-down
using GST-hTPC2-CT led to the speciﬁc enrichment of [35S]hHax-
1(178–279) compared to that performed with GST alone, indicat-
ing direct binding between hTPC2-CT and hHax-1. In addition,
GST pull-down using puriﬁed GST-hHax-1(178–279) speciﬁcally
enriched [35S]hTPC1-CT (Fig. 2B), indicating that hHax-1 also di-
rectly binds hTPC1 in agreement with the Y2H results.
3.3. hTPC2 co-immunoprecipitates with hHax-1
We next assessed whether the full-length hTPC2 channel forms
a protein complex with full-length hHax-1 in mammalian cells. We
performed co-IP experiments from HEK293 cells transiently co-
expressing HA-tagged hTPC2 and cMyc-tagged hHax-1. The HA
antibody was used for IP of HA-hTPC2 from solubilised HEK293
cells and the presence of co-precipitated cMyc–hHax-1 was ana-
lyzed by Western blotting using the cMyc antibody. As shown in
Fig. 3B, anti-HA resulted in very efﬁcient immunoprecipitation of
HA-hTPC2 (140 kDa), whereas non-immune control antibody
was negative. Importantly, anti-HA speciﬁcally co-precipitated
cMyc–hHax-1 (32 kDa) compared to non-immune control anti-
body (Fig. 3A), indicating that hTPC2 and hHax-1 exist in a protein
complex. As a further negative control, anti-HA IP from HEK293
cells expressing only HA-hTPC2 did not yield cMyc immunoreactive
32 kDa protein band corresponding to cMyc–hHax-1 (Fig. 3A).Fig. 2. GST pull-down assays conﬁrm the interaction between TPC1/2 and Hax-1.
(A) Puriﬁed GST-TPC2(694–752) or GST alone (to serve as negative control) were
incubated with in vitro synthesized [35S]Hax-1(178–279) and precipitated with
glutathione-Sepharose beads; co-precipitated radiolabelled Hax-1 (expected size of
13 kDa) was resolved through 12% SDS–PAGE gel and detected by autoradiography.
(B) Puriﬁed GST-Hax-1(178–279) or GST alone were incubated with in vitro
synthesized [35S]TPC1(686–816) and the presence of co-precipitated radiolabelled
TPC1 (expected size of 16 kDa) was analyzed by autoradiography. Aliquots of
radiolabelled protein (TnT) were included in the ﬁrst two lanes, corresponding to 1%
and 0.1% respectively, of the amount processed in the GST pull-down assays.4. Discussion
Here, we present biochemical evidence for a novel protein–pro-
tein interaction between hTPC1/2 and hHax-1, identiﬁed through
unbiased transcriptome-wide screens. Through independent inter-
action assays, we have veriﬁed that hHax-1 directly binds to both
hTPC1 and hTPC2. Moreover, we have mapped the minimal inter-
acting regions to the C-terminal half of hHax-1 (residues 178–
279) and to the C-terminal cytosolic domains of hTPC1 and hTPC2
(686–816 and 694–752, respectively).
Since its discovery in 1997 [25], Hax-1 has been implicated in
severe congenital neutropenia [26] and various cancers [27–30],
reﬂecting its important anti-apoptotic function at the whole-
organism level. Indeed, genetic ablation of the Hax-1 gene results
in excessive apoptosis of neurons and the loss of lymphocytes
[31], while overexpression of Hax-1 offers protection to various
pro-apoptotic stimuli [32]. Of the multiple roles proposed for its
anti-apoptotic function, the precise mechanisms relating to ion
handling reported to date include the attenuation of mitochondrial
depolarization [26] and inhibition of SERCA2a via phospholamban
to reduce sarcoplasmic reticulum Ca2+ levels [33–35]. These mech-
anisms likely attenuate the formation of the mitochondrial perme-
ability transition pore and the release of cytochrome C, thus
inhibiting apoptosis [36]. Our ﬁnding that Hax-1 interacts with
the recently identiﬁed endolysosomal TPCs is intriguing. Both
Hax-1 and TPC2 are ubiquitously expressed [2,3,37]. Hax-1 was
initially reported to localize mainly in mitochondria and also in
the endoplasmic reticulum [25], but further immunoﬂuorescence
studies revealed a predominantly cytoplasmic localization
[38,39]. TPC2 is predominantly found in the lysosomes with its
C-terminal tail facing the cytoplasm [2,3]. Given their overlapping
tissue expression and sub-cellular localization, it is likely that the
proposed TPC2 association with Hax-1 is physiologically relevant.
This novel interaction may add to the multiple indirect mecha-
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not be mutually exclusive but are likely cell-type dependent, as
Hax-1 localization, and likely its predominant function, is in part
dictated by the relative abundance of its binding partners [37].
First reported to be an important determinant of NAADP-in-
duced Ca2+ release [2,3,5,9], it was very recently suggested that
TPCs are Na+-selective channels regulated by PI(3,5)P2 and ATP
[10,11]. In addition, recent photoafﬁnity labeling studies indicated
that TPCs do not directly bind NAADP, and suggested that proteins
of 22/23 kDa in mammalian cells and 41 kDa in sea urchin eggs are
likely to be the NAADP receptor(s) [40,41]. Regardless of the pre-
cise properties of TPCs, it is possible that binding of Hax-1 to these
ion channels may alter channel function, for example gating prop-
erties, trafﬁcking, protein stability, which may in turn contribute to
the regulation of endolysosomal ion dynamics. Indeed, our ﬁnding
that Hax-1 interacts with both TPC1 and TPC2 may in fact repre-
sent a conserved mechanism by which these endolysosomal ion
channels are regulated. However, given the current controversy,
it is presently premature to predict precisely how the TPC:Hax-1
association may contribute to cellular function. Further investiga-
tions are needed to elucidate the underlying mechanism and func-
tional outcome of this novel protein–protein interaction.
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